Perrigo Reports Third Quarter 2024 Financial Results From Continuing Operations
Portfolio Pulse from
Perrigo reported its Q3 2024 financial results, showing a decline in net sales but growth in operating income and margins. The infant formula business is recovering, with significant market share gains and a 3% increase in net sales compared to the previous year. The company reaffirmed its fiscal 2024 adjusted EPS outlook.
November 06, 2024 | 11:45 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Perrigo's Q3 2024 results indicate a decline in net sales but improvements in operating income and margins. The infant formula segment is recovering, with market share gains and a 3% increase in net sales year-over-year. The company maintains its fiscal 2024 EPS outlook.
Despite a decline in overall net sales, Perrigo's operating income and margins improved, which is positive for the stock. The recovery in the infant formula segment, with market share gains and increased sales, further supports a positive outlook. The reaffirmation of the fiscal 2024 EPS outlook adds confidence to the company's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100